
Paraneoplastic neurological syndromes (PNS) are immune-mediated disorders associated with cancer and often precede tumor diagnosis. Identification of novel neural autoantigens may facilitate diagnosis and treatment. Sera or cerebrospinal fluid (CSF) from six patients showing a similar uncharacterized immunofluorescence staining pattern on rat hippocampal sections were collected. The target antigen was identified by immunoprecipitation and mass spectrometry and validated using established immunoassays. N-terminal EF-hand calcium-binding protein 1 (NECAB1) was revealed as target of the autoantibodies. Antigen identification was validated by competitive tissue IIFA, CBA, Western blot and line blot with the recombinant antigen. No reactivity was observed in CBA and line blot with 100 healthy controls or CBA with 303 disease controls. All five clinically characterized patients had breast or lung cancer and presented with limbic encephalitis (n = 3), cerebellar ataxia with cognitive decline (n = 1), or sensory-motor neuronopathy (n = 1). NECAB1 represents a novel autoantibody target in autoimmune neurological syndromes associated with lung or breast cancer. Samples from patients with suspected neurological autoimmune disorder showing the specific hippocampal interneuron IIFA pattern should be analyzed for NECAB1 autoantibodies by CBA or line blot and cancer screening should be considered.
Risdiplam improves motor function in spinal muscular atrophy (SMA), especially in children. In adults, subtle changes may not be captured by standard motor scales. To describe 24-month motor outcomes, perceived global change, and safety of risdiplam in adults with SMA types 2 and 3 in routine practice. In this retrospective two-center study, MFM-32, HFMSE, and RULM were assessed at baseline and after 6, 12, and 24 months, and patient- and clinician-rated Clinical Global Impression (CGI) at 12 and 24 months. All 24 patients (14 [58
Migraine is the most common neurological disorder, which after stroke confers the greatest neurological disability in the working population. As with other disorders of brain function, pathophysiological processes are more difficult to delineate, notwithstanding the biological complexities and clinical heterogeneity of the disorder. The current review will outline the framework upon which mechanistic pathways have been predicated. It will examine bench to bedside models: what we have learned from those which have been unsuccessful and address those which have borne fruit, presenting the clinical and exploratory insights gained. In the second part the more recent successes in drug therapeutics are summarised, from clinical trials to real world observations and limitations. With this in sight, the third part emphasises the need to reframe goals towards longer-term disease modification, addressing the impact of confounding comorbidities and moving towards a biopsychosocial model of pain.
Previous studies have documented impairments in social cognition and emotional reactivity in Huntington’s disease (HD), with a few highlighting the potential impact on daily functioning and quality of life (QoL). The aims of this study were to explore how patients’ self-reported social cognition was related to interoception, behavioural difficulties, carer burden and the QoL of both HD gene-carriers and their close others. A total of 36 patient-close-other dyads completed a range of scales to assess QoL, self-reported social cognition including affective empathy and perspective taking, social anxiety, interoception, patient apathy and functional capacity, and carer burden. Between group comparisons showed that gene-carriers exhibited lower QoL, emotional awareness, emotion contagion and perspective taking, as well as higher social anxiety and avoidance compared to close others. Patients’ QoL scores were predicted by specific aspects of interoception and affective empathy, but most consistently by social anxiety. Interoceptive attention regulation specifically, predicted patients’ functional capacity. While patient measures did not predict close-other QoL, carer burden was predicted by patients’ apathy and interoception in terms of bodily listening, attention regulation and emotional awareness. These findings suggest that HD is associated with interoceptive dysfunction, which contributes to impairments in emotional awareness and affective empathy, as well as carer burden, and behavioural difficulties as perceived by both patients themselves and their close others. While both impaired interoception and social anxiety directly impact QoL in HD, interoceptive dysfunction may exert a range of indirect influences through various affective symptoms from personal distress to apathy.